Matthew A. Lawlor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Matthew A. Lawlor has a total of 290 co-authors. Here are the top co-authors by number of shared publications:
- James E. Bradner
Novartis Institutes for Biomedical Research, Cambridge, USA
11 shared publications - Jaime M. Reyes
Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, USA
9 shared publications Jennifer A. Perry
9 shared publications- Jun Qi
Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA USA
9 shared publications - Charles Y. Lin
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
8 shared publications - Kwok-Kin Wong
Division of Hematology & Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, USA
8 shared publications
Latest Publications
- Open Access
- 9 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (32) , eadl1584
KAT2A and KAT2B prevent double-stranded RNA accumulation and interferon signaling to maintain intestinal stem cell renewal
Histone acetyltransferases KAT2A and KAT2B are paralogs highly expressed in the intestinal epithelium, but their functions are not well understood. In this study, double knockout of murine Kat2 genes in the intestinal epithelium was lethal, resulting in robust activation of interferon signaling and interferon-associated phenotypes including the loss of intestinal stem cells. Use of pharmacological agents and sterile organoid cultures indicated a cell-intrinsic double-stranded RNA trigger for interferon signaling. Acetyl-proteomics and sequencing of immunoprecipitated double-stranded RNA were used to interrogate the mechanism behind this response, which identified mitochondria-encoded double-stranded RNA as the source of intrinsic interferon signaling. Kat2a and Kat2b therefore play an essential role in regulating mitochondrial functions and maintaining intestinal health.
- 9 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (32) , eadl1584
Open AccessKAT2A and KAT2B prevent double-stranded RNA accumulation and interferon signaling to maintain intestinal stem cell renewal
Histone acetyltransferases KAT2A and KAT2B are paralogs highly expressed in the intestinal epithelium, but their functions are not well understood. In this study, double knockout of murine Kat2 genes in the intestinal epithelium was lethal, resulting in robust activation of interferon signaling and interferon-associated phenotypes including the loss of intestinal stem cells. Use of pharmacological agents and sterile organoid cultures indicated a cell-intrinsic double-stranded RNA trigger for interferon signaling. Acetyl-proteomics and sequencing of immunoprecipitated double-stranded RNA were used to interrogate the mechanism behind this response, which identified mitochondria-encoded double-stranded RNA as the source of intrinsic interferon signaling. Kat2a and Kat2b therefore play an essential role in regulating mitochondrial functions and maintaining intestinal health.
- Open Access
- 28 July 2023
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 82, 102092
Evolutionary dynamics between transposable elements and their host genomes: mechanisms of suppression and escape
- 28 July 2023
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 82, 102092
Open AccessEvolutionary dynamics between transposable elements and their host genomes: mechanisms of suppression and escape
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Information from A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Information from A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia